Medicinal cannabis industry reform Australia moves to remove regulatory burden
04 June 2020
The Life Sciences update can be viewed here.
The final report of the review of Australia's medicinal cannabis regulatory framework under the Narcotic Drugs Act 1967 (Cth) was tabled in Parliament on 5 September 2019.
All of the report's 26 recommendations, which aim to reduce the regulatory burden on the medicinal cannabis industry, were accepted by the Australian Government. This includes the replacement of the current three licence structure with the issue of a single licence.
A two-stage reform process has been proposed to ensure appropriate implementation.
In this update, Australian Government blazes a new trail for medicinal cannabis regulation, we explore the implementation of the 26 recommendations and the proposed single licence model.
For past legal updates in relation to medicinal cannabis, or to speak to the Ashurst team, please click here.
